Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Burden of Clinically Significant Bleeding, Thrombocytopenia and Platelet Transfusions in Myelodysplastic Syndromes

Kathleen Pao Lynn Cheok, MBBS, Rakchha Chhetri, MBBS, Li Yan A Wee, BSc (Hons), Arabelle Salvi, Bachelor of Pharmacy, Simon McRae, MD MBBS, MSc, David John Roxby, B App Sc, M App Sc, ARCPA, Deepak Singhal, MBBS, MD FRACP, FRCPA, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD

Blood (2019) 134 (Supplement_1): 719.

https://doi.org/10.1182/blood-2019-125273

Published: 2019

Journal Articles

Factor VIII gene ( F8 ) mutation and risk of inhibitor development in nonsevere hemophilia A

Corien L. Eckhardt, Alice S. van Velzen, Marjolein Peters, Jan Astermark, Paul P. Brons, Giancarlo Castaman, Marjon H. Cnossen, Natasja Dors, Carmen Escuriola-Ettingshausen, Karly Hamulyak, Daniel P. Hart, Charles R. M. Hay, Saturnino Haya, Waander L. van Heerde, Cedric Hermans, Margareta Holmström, Victor Jimenez-Yuste, Russell D. Keenan, Robert Klamroth, Britta A. P. Laros-van Gorkom, Frank W. G. Leebeek, Ri Liesner, Anne Mäkipernaa, Christoph Male, Evelien Mauser-Bunschoten, Maria G. Mazzucconi, Simon McRae, Karina Meijer, Michael Mitchell, Massimo Morfini, Marten Nijziel, Johannes Oldenburg, Kathelijne Peerlinck, Pia Petrini, Helena Platokouki, Sylvia E. Reitter-Pfoertner, Elena Santagostino, Piercarla Schinco, Frans J. Smiers, Berthold Siegmund, Annarita Tagliaferri, Thynn T. Yee, Pieter Willem Kamphuisen, Johanna G. van der Bom, Karin Fijnvandraat

Blood (2013) 122 (11): 1954–1962.

https://doi.org/10.1182/blood-2013-02-483263

Published: 2013

Includes: Supplemental data

Journal Articles

A Multi-Centre, Single-Arm, Open-Label Study Evaluating the Safety and Efficacy of Fixed Dose Rituximab in Patients with Refractory, Relapsing or Chronic Idiopathic Thrombocytopenic Purpura (R-ITP1000 Study) and Exploring Rituximab Response with the FcGammaR3A Polymorphisms

Huyen Tran, MBBS, MSc, FRACP, FRCPA, Jamie P Nourse, PhD, Rod Lea, PhD, Timothy A. Brighton, FRCPA, FRACP, MB, BS, MS, Andrew Grigg, MBBS, FRACP, FRCPA, Simon McRae, BMedSc, MBBS, FRACP, FRCPA, Daniel Thurley, MA, MB, BCHIR, Dep. pharm. med, MRCP, FFPM, Maher Gandhi, PhD, FRACP, FRCPath, FRCP, John Catalano, MBBS FRACP FRCPA

Blood (2011) 118 (21): 1157.

https://doi.org/10.1182/blood.V118.21.1157.1157

Published: 2011

Journal Articles

Laboratory Assays for Monitoring Rivaroxaban: In House in-Vitro Analysis and Review of Literature

Praveen Kumar Pathak, MD, Simon McRae, BMedSc, MBBS, FRACP, FRCPA, Elizabeth Duncan, Ian D Lewis, MBBS, PhD, Luen Bik To

Blood (2011) 118 (21): 4320.

https://doi.org/10.1182/blood.V118.21.4320.4320

Published: 2011

Journal Articles

Evaluation of a VENOus-Return Assist Device ( Venowave ™ ) To Treat Severe Post-Thrombotic Syndrome (VENOPTS): A Randomized Controlled Trial.

Martin O’Donnell, MB, Simon McRae, MD, Susan Kahn, MD MSc, Jim Julian, MMath, Clive Kearon, MB PhD, Betsy MacKinnon, MSc, Debbie Magier, RN, Carla Strulovitch, RN, Theresa Lyons, RN, Jack Hirsh, MD, Jeffrey Ginsberg, MD

Blood (2006) 108 (11): 877.

https://doi.org/10.1182/blood.V108.11.877.877

Published: 2006

NARROW

The Burden of Clinically Significant Bleeding, Thrombocytopenia and Platelet Transfusions in Myelodysplastic Syndromes

Factor VIII gene ( F8 ) mutation and risk of inhibitor development in nonsevere hemophilia A

A Multi-Centre, Single-Arm, Open-Label Study Evaluating the Safety and Efficacy of Fixed Dose Rituximab in Patients with Refractory, Relapsing or Chronic Idiopathic Thrombocytopenic Purpura (R-ITP1000 Study) and Exploring Rituximab Response with the FcGammaR3A Polymorphisms

Laboratory Assays for Monitoring Rivaroxaban: In House in-Vitro Analysis and Review of Literature

Evaluation of a VENOus-Return Assist Device ( Venowave ™ ) To Treat Severe Post-Thrombotic Syndrome (VENOPTS): A Randomized Controlled Trial.

Email alerts

ASH Publications

American Society of Hematology

The Burden of Clinically Significant Bleeding, Thrombocytopenia and Platelet Transfusions in Myelodysplastic Syndromes

Factor VIII gene ( F8 ) mutation and risk of inhibitor development in nonsevere hemophilia A

A Multi-Centre, Single-Arm, Open-Label Study Evaluating the Safety and Efficacy of Fixed Dose Rituximab in Patients with Refractory, Relapsing or Chronic Idiopathic Thrombocytopenic Purpura (R-ITP1000 Study) and Exploring Rituximab Response with the FcGammaR3A Polymorphisms

Laboratory Assays for Monitoring Rivaroxaban: In House in-Vitro Analysis and Review of Literature

Evaluation of a VENOus-Return Assist Device ( Venowave ™ ) To Treat Severe Post-Thrombotic Syndrome (VENOPTS): A Randomized Controlled Trial.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only